November 5, 2020 -- Avectas has become a resident at Johnson & Johnson Innovation (JLABS), a 40,000-sq-ft life science innovation center in Toronto, Canada.
The labs provide a flexible space for companies pursuing new technologies and research platforms. Johnson & Johnson Innovation does not take equity stakes in the companies occupying JLABS and the companies are free to develop products and establish external partnerships and collaboration as they see fit.
Avectas is the developer of Solupore, a patented, nonviral cell engineering technology for transfection in cell and gene therapy applications. The company partners with cell and gene therapy companies to address engineering cell delivery challenges, specifically cell modifications and engineering fragile or limited cells.
Avectas has also appointed Jessica Schwaber, PhD, as scientific director of cell and gene therapy as the first member of the technical operations team at the Toronto site.